Anti-cytokine therapy in fibrosing alveolitis: where are we now?
<p>Abstract</p> <p>Idiopathic pulmonary fibrosis (IPF) is a condition that has a poor prognosis, with a median survival of 4-5 years irrespective of treatment. Ziesche <it>et al</it> (<it>N Engl J Med</it> 1999, <b>341</b>: 1264-1269) describe an...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2000-06-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://respiratory-research.com/content/1/1/003 |